Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prokinetic agents in postgastrectomy patients

D J Patterson1

  • 1Section of Gastroenterology, Virginia Mason Medical Center, Seattle, Washington.

Gastroenterology Clinics of North America
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of the 7 & 7 Synch protocol and the 7-day CO-Synch + CIDR protocol among recipient beef cows in an embryo transfer program.

Theriogenology·2020
Same author

Comparison of long-term progestin-based protocols to synchronize estrus prior to natural service or fixed-time artificial insemination in Bos indicus-influenced beef heifers.

Animal reproduction science·2020
Same author

Altering duration of the presynchronization period in a long-term progestin-based estrus synchronization protocol for timed artificial insemination of beef heifers.

Theriogenology·2019
Same author

Evaluation of split-time artificial insemination following administration of a long or short-term progestin-based estrus synchronization protocol in beef heifers.

Theriogenology·2019
Same author

Evaluation of SexedULTRA 4M™ sex-sorted semen in timed artificial insemination programs for mature beef cows.

Theriogenology·2018
Same author

The 9-d CIDR-PG protocol II: Characterization of endocrine parameters, ovarian dynamics, and pregnancy rates to fixed-time AI following use of long-term CIDR-based estrus synchronization among mature beef cows.

Theriogenology·2017
Same journal

Living Donor Intestinal and Liver Transplantation.

Gastroenterology clinics of North America·2026
Same journal

Living Abdominal Organ Donation: A Plan B That Saves Lives.

Gastroenterology clinics of North America·2026
Same journal

Long-Term Outcomes of Living Liver Donors.

Gastroenterology clinics of North America·2026
Same journal

Perioperative Management of Living Liver Donor Patients.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Transplantation for Colorectal Cancer Liver Metastasis.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Graft in Adult Populations: Donor Selection and Workup.

Gastroenterology clinics of North America·2026
See all related articles

Postgastrectomy syndromes are challenging to treat, with prokinetic agents offering limited benefits. This review evaluates the effectiveness of current prokinetic drugs for managing these difficult post-surgical conditions.

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Postgastrectomy syndromes present significant challenges in patient care.
  • Current therapeutic options, particularly prokinetic agents, often yield suboptimal outcomes.

Purpose of the Study:

  • To critically evaluate the evidence supporting the efficacy of available prokinetic drugs.
  • To inform clinical decision-making for managing postgastrectomy syndromes.

Main Methods:

  • Systematic review of existing literature on prokinetic drug efficacy.
  • Analysis of clinical trial data and observational studies.

Main Results:

  • Evidence for the efficacy of most prokinetic agents in postgastrectomy syndromes is limited.
  • Specific agents may show marginal benefits for certain symptoms, but overall effectiveness remains questionable.

Related Experiment Videos

Conclusions:

  • Prokinetic agents offer limited benefit in managing postgastrectomy syndromes.
  • Further research is needed to identify more effective therapeutic strategies for these challenging conditions.